Yahoo · Oct 31, 2026
Why UnitedHealth Stock Can Still Gain After This Year’s 24% Rally
The health insurer’s third-quarter results helped reinforce the stock’s momentum.
NASDAQ · UNH
UNITEDHEALTH GROUP INCORPORATED (Delaware)
Healthcare · Medical - Healthcare Plans
$406.97
Down-$3.94 (-0.96%)
Updated Oct 31, 2026, 6:50 PM
SID Score
7.7/10
Composite research score
Smart Money
41/100
Neutral
- Market cap
- 305B
- P/E ratio
- 17.38
- Dividend yield
- 2.15%
- 52-week range
- $255.97 – $461.62
- Volume
- 4.3M
- Avg. volume
- 8.77M
Price performance · UNH
UNH price history
1M range · 21 trading sessions · Daily adjusted prices
Prices through Oct 30, 2026
UNH closed at $406.97 after 21 trading sessions, up 9.43% for the selected period.
- Last close
- $406.97
- Period change
- +9.43%
- Period low
- $370.95
- Period high
- $424.98
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 30, 2026 | $415.00 | $416.11 | $405.91 | $406.97 | 4.3M |
| Oct 29, 2026 | $413.71 | $414.76 | $404.31 | $410.91 | 3.8M |
| Oct 28, 2026 | $407.00 | $416.19 | $405.00 | $407.10 | 3.9M |
| Oct 27, 2026 | $412.72 | $413.5975 | $408.22 | $410.39 | 3.75M |
| Oct 26, 2026 | $418.99 | $420.8599 | $408.35 | $410.70 | 4.59M |
| Oct 23, 2026 | $424.30 | $425.25 | $416.37 | $418.09 | 3.89M |
| Oct 22, 2026 | $418.38 | $426.55 | $417.13 | $424.98 | 5.42M |
| Oct 21, 2026 | $421.80 | $421.80 | $415.00 | $417.00 | 3.99M |
| Oct 20, 2026 | $410.12 | $422.40 | $408.28 | $419.26 | 6.82M |
| Oct 19, 2026 | $399.69 | $408.50 | $399.20 | $406.88 | 5M |
| Oct 16, 2026 | $410.35 | $412.37 | $395.5175 | $401.43 | 8.11M |
| Oct 15, 2026 | $401.24 | $414.12 | $400.00 | $406.67 | 10.16M |
| Oct 14, 2026 | $382.29 | $396.44 | $382.29 | $395.62 | 7.77M |
| Oct 13, 2026 | $397.625 | $399.88 | $372.80 | $377.76 | 12.65M |
| Oct 12, 2026 | $382.98 | $382.98 | $373.67 | $378.52 | 5.91M |
| Oct 9, 2026 | $373.94 | $387.52 | $373.02 | $379.30 | 7.47M |
| Oct 8, 2026 | $375.38 | $376.45 | $368.50 | $370.95 | 7.29M |
| Oct 7, 2026 | $375.92 | $383.48 | $372.01 | $375.98 | 5.63M |
| Oct 6, 2026 | $379.03 | $380.41 | $373.70 | $376.32 | 5.04M |
| Oct 5, 2026 | $372.33 | $379.14 | $368.0501 | $378.58 | 5.83M |
| Oct 2, 2026 | $365.14 | $372.68 | $364.47 | $371.90 | 3.31M |
Latest UNH news
The latest Smart Investors Daily articles mentioning UNH.
Stock researchCompany · Overview
Company
Market Activity
Research & News
UNH research
Overview
Company profile and research snapshot.
Company profile
UnitedHealth Group is one of the largest private health insurers and provides medical benefits to about 51 million members globally, including 1 million outside the US as of December 2024. As a leader in employer-sponsored, self-directed, and government-backed insurance plans, UnitedHealth has obtained massive scale in medical insurance. Along with its insurance assets, UnitedHealth's Optum franchises help create a healthcare services colossus that spans everything from pharmaceutical benefits to providing outpatient care and analytics to both affiliated and third-party customers.
Visit company websiteAnalyst outlook
Consensus and target data currently published for this company.
- Consensus
- Buy
- Average target
- $387.80
- Implied upside
- —
- Analysts
- 20
| Date | Firm | Rating | Target |
|---|---|---|---|
| Oct 27, 2026 | Wells Fargo | Overweight | — |
| Oct 27, 2026 | Morgan Stanley | Overweight | — |
| Oct 22, 2026 | Mizuho | Outperform | — |
| Oct 20, 2026 | RBC Capital | Outperform | — |
| Oct 16, 2026 | JP Morgan | Overweight | — |
News briefing
No generated briefing is available yet.
Yahoo · Oct 30, 2026
What UnitedHealth Group Bulls Got Right
If you had been weighing UnitedHealth Group on 1 January 2026, you were staring at a business fresh off a difficult 2025, with analysts split between a Medicare margin squeeze and an AI powered recovery. Investors who held UnitedHealth Group from the start of the year are up 24.6%, including dividends. The real question now is what those early buyers saw in the aging population, AI spend, and rising regulatory heat that felt worth the risk. Narratives are how investors here put a case on the...
Yahoo · Oct 30, 2026
BridgeBio's Heart Disorder Drug Attruby Faces Unanticipated Near-Term Tailwinds, UBS Says
BridgeBio Pharma's (BBIO) heart disorder drug Attruby faces near-term tailwinds from the likely appr
Yahoo · Oct 30, 2026
1 safe-and-steady stock to research further and 2 we find risky
Stability is great, but low-volatility stocks may struggle to deliver market-beating returns over time as they sometimes underperform during bull markets.
AI research layers
Interpretive context generated from the platform’s current data sources.
UnitedHealth Group Stock Performance
UnitedHealth Group shares closed at $406.97, reflecting a daily decline of approximately 1.02%, per SID market data. Over the trailing one-month period, the stock has gained $11.44, though three-month performance shows a modest decline of $2.02, indicating recent volatility in the healthcare sector. On a one-year basis, UNH has appreciated by $16.62, underperforming broader market indices. The stock currently trades above both its 50-day moving average of $390.20 and its 200-day moving average of $361.05, according to Massive/Polygon technical data, suggesting a sustained intermediate-term uptrend. The 14-day relative strength index stands at 66.1, approaching but not yet breaching overbought territory. UNH maintains a beta of 0.432, reflecting significantly lower volatility relative to the broader market. Average daily trading volume registers at approximately 8.77 million shares, supporting adequate liquidity for institutional positioning.
UnitedHealth Group Valuation Analysis
UnitedHealth Group carries a market capitalization of approximately $305 billion, positioning it as one of the largest companies in the healthcare sector, per SID market data. The stock trades at a price-to-earnings ratio of 17.38, which remains moderate relative to large-cap peers in managed care. The price-to-book ratio stands at 3.19, according to SEC filings, reflecting the market's premium valuation of UNH's intangible assets and earnings power. Notably, the PEG ratio registers at negative 1.02, a metric distorted by current earnings growth trajectory adjustments that warrant careful interpretation. UnitedHealth offers a dividend yield of approximately 2.59%, providing income-oriented investors with a meaningful return component. The combination of a sub-20 P/E ratio and a dividend yield above 2.5% positions UNH within the value segment of the large-cap healthcare landscape, distinguishing it from higher-multiple growth-oriented peers in the broader market.
Smart Money Activity for UNH
UnitedHealth Group's composite smart money score stands at 41 out of 100, generating a neutral signal according to SID market data. The institutional component scores a perfect 25 out of 25, indicating maximum conviction from large asset managers and hedge funds based on 13F institutional filings. In contrast, the insider score registers at 0 out of 25 despite notable activity: 20 insider transactions have been recorded over the past 90 days, all classified as purchases with zero sells, per SEC Form 4 filings. This all-buy pattern among corporate insiders suggests internal confidence, though the low insider sub-score may reflect the relatively small dollar amounts of those transactions relative to outstanding shares. Dark pool activity scores 12.2 out of 25, indicating moderate off-exchange institutional interest. Congressional trading activity contributes a modest 4.0 out of 25. The divergence between strong institutional conviction and the overall neutral composite score reflects mixed signals across the remaining smart money subcategories, requiring investors to weigh individual components independently.
UnitedHealth Group Earnings Outlook
UnitedHealth Group has delivered consistent earnings beats across its three most recent reported quarters, according to company earnings reports. In the most recent quarter reported on April 21, 2026, UNH posted earnings per share of $7.23 against a consensus estimate of $6.56, representing a positive surprise of $0.67 or approximately 10.2%. The July 2026 quarter produced the largest beat, with actual EPS of $6.38 versus the $4.85 estimate, a $1.53 positive surprise representing a 31.5% upside. The October 2026 quarter also exceeded expectations, delivering $4.69 against a $4.14 estimate. Looking ahead, analysts project EPS of $4.14 for the upcoming quarter with results expected on October 27, 2026. The pattern of sequential earnings surprises demonstrates operational execution that has repeatedly surpassed analyst modeling assumptions, particularly in medical cost management and premium revenue growth across the company's diversified healthcare platform.
Wall Street Analyst Ratings for UNH
Wall Street consensus on UnitedHealth Group remains uniformly positive, with all five most recent analyst actions reiterating bullish ratings, per Wall Street analyst reports. On October 27, 2026, both Wells Fargo and Morgan Stanley maintained their Overweight ratings on UNH, signaling continued conviction in the company's earnings trajectory. Mizuho reiterated its Outperform rating on October 22, while RBC Capital maintained its Outperform designation on October 20, according to SID consensus data. JP Morgan also sustained its Overweight rating on October 16, 2026. Notably, none of the five recent analyst actions involved a rating change — all were reaffirmations of prior bullish positions, suggesting stable institutional sentiment rather than shifting momentum. The absence of any Hold, Underweight, or Sell ratings among recent coverage updates reflects broad agreement across major investment banks regarding UNH's fundamental positioning within the managed care industry and its capacity to deliver sustained shareholder returns amid evolving healthcare policy dynamics.
